Back to search
FDAFDA · Food and drugs·Recall number D-0732-2026

Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-401-10.

Published July 29, 2026 · Recall initiated: June 24, 2026

Summary

FDA records drug Class I recall D-0732-2026, published July 29, 2026 and initiated June 24, 2026. Recalling firm: JB Chemicals and Pharmaceuticals Ltd; Status: Ongoing; Reported quantity: 34,020 100-count bottles.; Lot: Lots: GY825029, GY825030, GY825031, GY825032, expires: 2028-OCT. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.

What to do

Voluntary: Firm initiated · Letter

Get an email if CETIRIZINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CETIRIZINE HYDROCHLORIDE
Manufacturer
JB Chemicals and Pharmaceuticals Ltd
Distributor
Nationwide in the USA
Lot
Lots: GY825029, GY825030, GY825031, GY825032, expires: 2028-OCT
Risk classification
Class I
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-401-10. recalled?

Yes. FDA published recall D-0732-2026 on July 29, 2026. Reported hazard: Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CETIRIZINE HYDROCHLORIDE.